Patents by Inventor Sing Sing Way

Sing Sing Way has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240309075
    Abstract: Disclosed are methods of modulating antibody function, in particular, via modifying one or more terminal sialic acid residues of an antibody. In certain aspects, the antibody may be an IgG antibody, wherein one or more terminal sialic acid residues is modified to modulate the antibody function. Further disclosed are methods of using such modified antibodies, and compositions comprising modified antibodies.
    Type: Application
    Filed: March 4, 2022
    Publication date: September 19, 2024
    Inventors: Sing Sing Way, John Erickson
  • Publication number: 20190183950
    Abstract: Compositions and methods of modulating immune responses (e.g., immune responses mediated by Th17 CD4+ T cells), involving fungal cells (Candida cells or yeast cells), extracts thereof comprising mannan molecules, anti-fungal agents, and/or mycotic probiotics.
    Type: Application
    Filed: December 19, 2018
    Publication date: June 20, 2019
    Applicant: Children's Hospital Medical Center
    Inventor: Sing Sing Way
  • Publication number: 20180022810
    Abstract: Provided herein are compositions and methods related to reducing the risk of or preventing fetal wastage in a subject using a CXCR3 inhibitor.
    Type: Application
    Filed: February 4, 2016
    Publication date: January 25, 2018
    Applicant: Children's Hospital Medical Center
    Inventor: Sing Sing Way
  • Patent number: 9499628
    Abstract: In an aspect, a method of augmenting an immune response in a subject in need thereof, comprising identifying the subject, and treating the subject to inhibit the immune suppressive effect of CD71+ cells is provided. Further provided is a method of preventing, treating or ameliorating an infection in a subject, comprising administering to the subject an agent that reduces the level of CD71+ cells in the subject.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: November 22, 2016
    Assignee: Children's Hospital Medical Center
    Inventor: Sing Sing Way
  • Publication number: 20140370004
    Abstract: In an aspect, a method of augmenting an immune response in a subject in need thereof, comprising identifying the subject, and treating the subject to inhibit the immune suppressive effect of CD71+ cells is provided. Further provided is a method of preventing, treating or ameliorating an infection in a subject, comprising administering to the subject an agent that reduces the level of CD71+ cells in the subject.
    Type: Application
    Filed: June 13, 2014
    Publication date: December 18, 2014
    Inventor: Sing Sing Way